BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1828119)

  • 1. Stochastic analysis of intermediate lesions in carcinogenesis experiments.
    Luebeck EG; Moolgavkar SH
    Risk Anal; 1991 Mar; 11(1):149-57. PubMed ID: 1828119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
    Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
    Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
    Moore MA; Hacker HJ; Kunz HW; Bannasch P
    Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis).
    Grasl-Kraupp B; Luebeck G; Wagner A; Löw-Baselli A; de Gunst M; Waldhör T; Moolgavkar S; Schulte-Hermann R
    Carcinogenesis; 2000 Jul; 21(7):1411-21. PubMed ID: 10874021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
    Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
    Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis.
    Enzmann H; Zerban H; Kopp-Schneider A; Löser E; Bannach P
    Carcinogenesis; 1995 Jul; 16(7):1513-8. PubMed ID: 7614684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biologically based model for the analysis of premalignant foci of arbitrary shape.
    Dewanji A; Luebeck EG; Moolgavkar SH
    Math Biosci; 1996 Jul; 135(1):55-68. PubMed ID: 8688565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-nitrosomorpholine and phenobarbital on UDP-glucuronyltransferase in putative preneoplastic foci of rat liver.
    Fischer G; Ulrich D; Bock KW
    Carcinogenesis; 1985 Apr; 6(4):605-9. PubMed ID: 2859128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic description of initiation and promotion in experimental carcinogenesis.
    Luebeck EG; Moolgavkar SH
    Ann Ist Super Sanita; 1991; 27(4):575-80. PubMed ID: 1840318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
    Sherman CD; Portier CJ
    Carcinogenesis; 1995 Oct; 16(10):2499-506. PubMed ID: 7586158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
    Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
    Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
    Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
    Carcinogenesis; 1993 Dec; 14(12):2601-4. PubMed ID: 7903604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis.
    Rabes HM; Szymkowiak R
    Cancer Res; 1979 Apr; 39(4):1298-304. PubMed ID: 154362
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement by ethyl alcohol of experimental hepatocarcinogenesis induced by N-nitrosomorpholine.
    Tatsuta M; Iishi H; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
    Int J Cancer; 1997 Jun; 71(6):1045-8. PubMed ID: 9185709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of hepatocarcinogenesis in rats by dietary fructose.
    Enzmann H; Ohlhauser D; Dettler T; Bannasch P
    Carcinogenesis; 1989 Jul; 10(7):1247-52. PubMed ID: 2567639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ethanol on early stages in nitrosamine carcinogenesis in rat liver.
    Schwarz M; Buchmann A; Wiesbeck G; Kunz W
    Cancer Lett; 1983 Oct; 20(3):305-12. PubMed ID: 6226354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by neurotensin of hepatocarcinogenesis by N-nitrosomorpholine in Sprague-Dawley rats.
    Nakaizumi A; Uehara H; Baba M; Iishi H; Tatsuta M
    Cancer Lett; 1996 Dec; 110(1-2):57-61. PubMed ID: 9018081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.